Please login to the form below

Not currently logged in
Email:
Password:

Samsung Bioepis

This page shows the latest Samsung Bioepis news and features for those working in and with pharma, biotech and healthcare.

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

The ruling also delays the date on which Sandoz and Samsung Bioepis, which became the second company to win FDA approval for an Enbrel biosimilar in April, can begin recouping returns

Latest news

More from news
Approximately 15 fully matching, plus 38 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics